公开(公告)号：US07933646B2

公开(公告)日：2011-04-26

申请号：US11837987

申请日：2007-08-13

申请人： Mark G. Frei ,  Ivan Osorio ,  Nina M. Graves ,  Scott F. Schaffner ,  Mark T. Rise ,  Jonathon E. Giftakis ,  David L. Carlson

发明人： Mark G. Frei ,  Ivan Osorio ,  Nina M. Graves ,  Scott F. Schaffner ,  Mark T. Rise ,  Jonathon E. Giftakis ,  David L. Carlson

IPC分类号： A61B5/04

CPC分类号： A61M5/1723 ,  A61B5/04001 ,  A61B5/0476 ,  A61B5/4094 ,  A61B5/6843 ,  A61B5/721 ,  A61N1/36025 ,  A61N1/36064 ,  A61N1/36082 ,  A61N1/361

摘要： Apparatus and method detect a detection cluster that is associated with a neurological event, such as a seizure, of a nervous system disorder and update therapy parameters that are associated with a treatment therapy. The occurrence of the detection cluster is detected when the maximal ratio exceeds an intensity threshold. If the maximal ratio drops below the intensity threshold for a time interval that is less than a time threshold and subsequently rises above the intensity threshold, the subsequent time duration is considered as being associated with the detection cluster rather than being associated with a different detection cluster. Consequently, treatment of the nervous system disorder during the corresponding time period is in accordance with one detection cluster. Treatment therapy may be provided by providing electrical stimulation, drug infusion or a combination. Therapy parameters may be updated for each mth successive group of applications of the treatment therapy or for each nth detection cluster.

摘要翻译： 装置和方法检测与神经系统疾病的神经系统事件（例如癫痫发作），与治疗疗法相关联的更新治疗参数相关联的检测簇。 当最大比例超过强度阈值时，检测到簇的出现。 如果最小比率在低于时间阈值的时间间隔下降到低于强度阈值，并且随后升高到强度阈值以上，则后续持续时间被认为与检测集群相关联，而不是与不同的检测集群相关联 。 因此，在相应时间段期间治疗神经系统疾病是根据一个检测群。 可以通过提供电刺激，药物输注或组合来提供治疗治疗。 治疗参数可以针对治疗疗法或第n个检测簇的每个第m个连续的应用组进行更新。

公开(公告)号：US07280867B2

公开(公告)日：2007-10-09

申请号：US10687571

申请日：2003-10-15

申请人： Mark G. Frei ,  Ivan Osorio ,  Nina M. Graves ,  Scott F. Schaffner ,  Mark T. Rise ,  Jonathon E. Giftakis ,  David L. Carlson

发明人： Mark G. Frei ,  Ivan Osorio ,  Nina M. Graves ,  Scott F. Schaffner ,  Mark T. Rise ,  Jonathon E. Giftakis ,  David L. Carlson

IPC分类号： A61B5/04

CPC分类号： A61B5/04012 ,  A61B5/0476 ,  A61B5/4094 ,  A61B5/7217 ,  A61N1/36025 ,  A61N1/36082 ,  A61N1/361 ,  Y10S128/92

摘要： Apparatus and method detect a detection cluster that is associated with a neurological event, such as a seizure, of a nervous system disorder and update therapy parameters that are associated with a treatment therapy. The occurrence of the detection cluster is detected when the maximal ratio exceeds an intensity threshold. If the maximal ratio drops below the intensity threshold for a time interval that is less than a time threshold and subsequently rises above the intensity threshold, the subsequent time duration is considered as being associated with the detection cluster rather than being associated with a different detection cluster. Consequently, treatment of the nervous system disorder during the corresponding time period is in accordance with one detection cluster. Treatment therapy may be provided by providing electrical stimulation, drug infusion or a combination. Therapy parameters may be updated for each mth successive group of applications of the treatment therapy or for each nth detection cluster.

摘要翻译： 装置和方法检测与神经系统疾病的神经系统事件（例如癫痫发作），与治疗疗法相关联的更新治疗参数相关联的检测簇。 当最大比例超过强度阈值时，检测到簇的出现。 如果最小比率在低于时间阈值的时间间隔下降到低于强度阈值，并且随后升高到强度阈值以上，则后续持续时间被认为与检测集群相关联，而不是与不同的检测集群相关联 。 因此，在相应时间段期间治疗神经系统疾病是根据一个检测群。 可以通过提供电刺激，药物输注或组合来提供治疗治疗。 治疗参数可以针对治疗疗法的每个连续的应用组或每个第n个检测簇进行更新。

公开(公告)号：US08738136B2

公开(公告)日：2014-05-27

申请号：US11837994

申请日：2007-08-13

申请人： Mark G. Frei ,  Ivan Osorio ,  Nina M. Graves ,  Scott F. Schaffner ,  Mark T. Rise ,  Jonathon E. Giftakis ,  David L. Carlson

发明人： Mark G. Frei ,  Ivan Osorio ,  Nina M. Graves ,  Scott F. Schaffner ,  Mark T. Rise ,  Jonathon E. Giftakis ,  David L. Carlson

IPC分类号： A61N1/36

CPC分类号： A61M5/1723 ,  A61B5/04001 ,  A61B5/0476 ,  A61B5/4094 ,  A61B5/6843 ,  A61B5/721 ,  A61N1/36025 ,  A61N1/36064 ,  A61N1/36082 ,  A61N1/361

摘要： Apparatus and method detect a detection cluster that is associated with a neurological event, such as a seizure, of a nervous system disorder and update therapy parameters that are associated with a treatment therapy. The occurrence of the detection cluster is detected when the maximal ratio exceeds an intensity threshold. If the maximal ratio drops below the intensity threshold for a time interval that is less than a time threshold and subsequently rises above the intensity threshold, the subsequent time duration is considered as being associated with the detection cluster rather than being associated with a different detection cluster. Consequently, treatment of the nervous system disorder during the corresponding time period is in accordance with one detection cluster. Treatment therapy may be provided by providing electrical stimulation, drug infusion or a combination. Therapy parameters may be updated for each mth successive group of applications of the treatment therapy or for each nth detection cluster.

摘要翻译： 装置和方法检测与神经系统疾病的神经系统事件如癫痫发作相关联的检测簇，以及与治疗疗法相关联的更新治疗参数。 当最大比例超过强度阈值时，检测到簇的出现。 如果最小比率在低于时间阈值的时间间隔下降到低于强度阈值，并且随后升高到强度阈值以上，则后续持续时间被认为与检测集群相关联，而不是与不同的检测集群相关联 。 因此，在相应时间段期间治疗神经系统疾病是根据一个检测群。 可以通过提供电刺激，药物输注或组合来提供治疗治疗。 治疗参数可以针对治疗疗法或第n个检测簇的每个第m个连续的应用组进行更新。

公开(公告)号：US08579786B2

公开(公告)日：2013-11-12

申请号：US10687344

申请日：2003-10-15

申请人： Ivan Osorio ,  Mark G. Frei ,  Naresh C. Bhavaraju ,  Thomas E. Peters ,  Nina M. Graves ,  Scott F. Schaffner ,  Jonathon E. Giftakis ,  Mark T. Rise ,  Jonathan C. Werder

发明人： Ivan Osorio ,  Mark G. Frei ,  Naresh C. Bhavaraju ,  Thomas E. Peters ,  Nina M. Graves ,  Scott F. Schaffner ,  Jonathon E. Giftakis ,  Mark T. Rise ,  Jonathan C. Werder

IPC分类号： A61N2/00

CPC分类号： A61N1/08 ,  A61B5/0476 ,  A61B5/4094 ,  A61B5/7275 ,  A61N1/36025 ,  A61N1/36082 ,  A61N1/361 ,  A61N1/37217

摘要： Apparatus and method support a neurological event screening for a medical device. The medical device assists a user in determining a configuration of the medical device for delivering an effective treatment for a nervous system disorder. The medical device detects a neurological event, such as a seizure, and reports a neurological event focus location and a neurological event spread to the user. The user may use the information to provide a configuration of a therapeutic delivery unit and associated therapy parameters. Therapeutic treatment is delivered to the patient, and the medical device is provided an indication of the patient's acceptance to the treatment. The user may modify the configuration and therapy parameters in order to achieve efficacy and acceptance. Depending upon the patient's acceptance, therapy is applied in either an open loop mode or a closed loop mode. The medical device determines whether the treatment is successful in accordance with a criterion.

摘要翻译： 装置和方法支持用于医疗装置的神经事件筛查。 医疗装置帮助用户确定医疗装置的配置以递送用于神经系统障碍的有效治疗。 医疗装置检测诸如癫痫发作的神经系统事件，并向用户报告神经系统事件焦点位置和神经系统事件。 用户可以使用该信息来提供治疗递送单元的配置和相关联的治疗参数。 向患者传送治疗性治疗，并且向患者提供患者接受治疗的指示。 用户可以修改配置和治疗参数，以达到功效和验收。 根据患者的接受程度，治疗以开环模式或闭环模式应用。 医疗设备根据标准确定治疗是否成功。

公开(公告)号：US07242983B2

公开(公告)日：2007-07-10

申请号：US10687133

申请日：2003-10-15

申请人： Mark G. Frei ,  Ivan Osorio ,  Mark T. Rise ,  Jonathon E. Giftakis ,  Nina M. Graves ,  David L. Carlson ,  Randy M. Jensen

发明人： Mark G. Frei ,  Ivan Osorio ,  Mark T. Rise ,  Jonathon E. Giftakis ,  Nina M. Graves ,  David L. Carlson ,  Randy M. Jensen

IPC分类号： A61N1/00

CPC分类号： A61N1/37264 ,  A61N1/36146 ,  A61N2/00

摘要： Apparatuses and methods selectively blank a neurological channel of a medical device system in the treatment of a nervous system disorder. A selected signal of a selected channel may be blanked if it is determined that the selected signal may be affected by an artifact when the medical device system delivers a treatment therapy. The selected signal may be blanked by hardware, in which the selected electrode is disconnected from the selected channel (which may include an selected amplifier) and is connected to a fixed voltage in order to avoid saturation of the selected amplifier. The selected channel may be blanked by software, in which a signal processor is instructed not to process neurological data on the selected channel for a determined time duration. Embodiments may combine hardware and software blanking for the selected signal.

摘要翻译： 装置和方法选择性地将医疗装置系统的神经通道置于神经系统疾病的治疗中。 如果在医疗设备系统递送治疗疗法时确定所选择的信号可能受到伪像的影响，则选定信道的所选信号可能被消隐。 所选择的信号可能被硬件消隐，其中所选择的电极与所选择的通道（其可以包括所选择的放大器）断开连接，并且连接到固定电压，以避免所选放大器的饱和。 所选择的通道可以被软件置空，其中指示信号处理器不在所选择的通道上处理确定的持续时间的神经学数据。 实施例可以组合所选信号的硬件和软件消隐。

公开(公告)号：US08594798B2

公开(公告)日：2013-11-26

申请号：US10687289

申请日：2003-10-15

申请人： Ivan Osorio ,  Mark G. Frei ,  Mark T. Rise ,  Scott F. Schaffner ,  Nina M. Graves

发明人： Ivan Osorio ,  Mark G. Frei ,  Mark T. Rise ,  Scott F. Schaffner ,  Nina M. Graves

IPC分类号： A61N1/08

CPC分类号： A61N1/36025 ,  A61N1/08 ,  A61N1/36082

摘要： Apparatuses and methods support multi-modal operation of a medical device system for a nervous system disorder. The medical device system comprises an implanted component and an external component and supports a first feature and a second feature that are associated with the treatment therapy. The medical device system supports both features when the implanted component and the external component are coupled. If the external component is decoupled, the implanted component continues to support the first feature. Moreover, the embodiment may support a plurality of features during a treatment interval. Another aspect of the invention allows for modularly expanding a medical device system in order to add a feature that enhances existing functionality or that provides additional functionality. In an embodiment, a module that is associated with an external component of the medical device system supports the added feature.

摘要翻译： 装置和方法支持用于神经系统障碍的医疗装置系统的多模式操作。 医疗装置系统包括植入部件和外部部件，并且支撑与治疗疗法相关联的第一特征和第二特征。 当植入部件和外部部件联接时，医疗装置系统支持两个特征。 如果外部组件解耦，则植入组件继续支持第一个特征。 此外，该实施例可以在治疗间隔期间支持多个特征。 本发明的另一方面允许模块化地扩展医疗设备系统，以便添加增强现有功能或提供附加功能的特征。 在一个实施例中，与医疗设备系统的外部部件相关联的模块支持附加的特征。

公开(公告)号：US20100114237A1

公开(公告)日：2010-05-06

申请号：US12608815

申请日：2009-10-29

申请人： Jonathon E. Giftakis ,  Mark T. Rise ,  David L. Carlson ,  Paul H. Stypulkowski ,  Scott R. Stanslaski ,  Randy M. Jensen ,  Timothy J. Denison

发明人： Jonathon E. Giftakis ,  Mark T. Rise ,  David L. Carlson ,  Paul H. Stypulkowski ,  Scott R. Stanslaski ,  Randy M. Jensen ,  Timothy J. Denison

IPC分类号： A61N1/00

CPC分类号： A61B5/0476 ,  A61B5/0205 ,  A61B5/024 ,  A61B5/0488 ,  A61B5/16 ,  A61B5/165 ,  A61B5/4076 ,  A61B5/4839 ,  A61B5/486 ,  A61M21/00 ,  A61M2021/0072 ,  A61N1/0529 ,  A61N1/0531 ,  A61N1/0534 ,  A61N1/36082

摘要： Brain signals may be monitored at different locations of a mood circuit in order to determine a mood state of the patient. A relationship (e.g., a ratio) between frequency band characteristics of the monitored brain signals may be indicative of a particular mood state. In some examples, therapy parameter values that define the therapy delivered to the patient may be selected to maintain a target relationship (e.g., a target ratio) between the frequency band characteristics of the brain signals monitored within the mood circuit. In addition, in some examples, therapy delivery to the patient may be controlled based on the frequency band characteristics of brain signals sensed at different portions of the mood circuit.

摘要翻译： 可以在心情电路的不同位置监测脑信号，以便确定患者的情绪状态。 所监视的脑信号的频带特性之间的关系（例如，比率）可以指示特定的情绪状态。 在一些示例中，可以选择限定递送给患者的治疗的治疗参数值，以在心情电路内监测的脑信号的频带特性之间维持目标关系（例如，目标比率）。 此外，在一些示例中，可以基于在心情电路的不同部分感测到的脑信号的频带特性来控制对患者的治疗递送。

公开(公告)号：US10688303B2

公开(公告)日：2020-06-23

申请号：US12425758

申请日：2009-04-17

申请人： Mark T. Rise ,  Jonathon E. Giftakis

发明人： Mark T. Rise ,  Jonathon E. Giftakis

IPC分类号： A61N1/36

摘要： Target tissue sites for therapy delivery to a patient may be selected based on the patient symptoms or a patient mood state. The therapy delivery may be used to manage a psychiatric disorder of the patient. Selected therapy sites may be weighted based on factors, such as the severity of the patient symptom or mood state or the type of patient symptom or mood state. In some cases, therapy delivery to the patient may be controlled based on the weighting factors. For example, the weighting factors may control the intensity of the therapy delivery or the frequency of the therapy delivery. In some examples, the weighting factors may dynamically change based on the patient's changing symptoms or mood disorders.

公开(公告)号：US09613184B2

公开(公告)日：2017-04-04

申请号：US12426065

申请日：2009-04-17

申请人： Jonathon E. Giftakis ,  Mark T. Rise ,  Paul H. Stypulkowski ,  Timothy J. Denison

发明人： Jonathon E. Giftakis ,  Mark T. Rise ,  Paul H. Stypulkowski ,  Timothy J. Denison

IPC分类号： A61N1/00 ,  G06F19/00 ,  A61M5/142 ,  A61N1/08 ,  A61N1/36 ,  A61M5/172 ,  A61N1/372

CPC分类号： G16H40/63 ,  A61M5/14276 ,  A61M5/1723 ,  A61M2005/14208 ,  A61M2205/3561 ,  A61M2205/3592 ,  A61M2210/0693 ,  A61N1/08 ,  A61N1/36025 ,  A61N1/36082 ,  A61N1/37211 ,  G06F19/00 ,  G16H40/40

摘要： A characteristic of a washout period following the delivery of therapy to a patient according to a therapy program may be determined based on a physiological parameter of the patient. A washout period includes the period of time during which a carryover effect from the therapy dissipates. The washout period characteristic may include, for example, a duration of the washout period, an amplitude or a trend in a physiological signal during the washout period or a power level or a ratio of power levels in frequency bands of the physiological signal. In some embodiments, washout period characteristics associated with a plurality of therapy programs may be used to compare the programs. In other embodiments, a washout period characteristic may be used to determine a mood state of the patient and, in some cases, modify a therapy program. Monitoring a washout period may also be useful for timing therapy program trials.

公开(公告)号：US20120116475A1

公开(公告)日：2012-05-10

申请号：US13288797

申请日：2011-11-03

申请人： Dwight E. Nelson ,  Jianping Wu ,  Jonathon E. Giftakis ,  Mark T. Rise

发明人： Dwight E. Nelson ,  Jianping Wu ,  Jonathon E. Giftakis ,  Mark T. Rise

IPC分类号： A61N1/36

CPC分类号： A61N1/00 ,  A61N1/0534 ,  A61N1/37247 ,  A61N1/37264 ,  A61N1/37282

摘要： In some examples, an arousal network of a brain of a patient can be activated to modify the arousal state of the patient, which may be useful in treating a cognitive disorder of the patient. In some examples, a bioelectrical brain signal indicative of electrical activity in a first portion of the brain is monitored to determine whether the patient is in a first arousal state, and, in response to determining the patient is in the first arousal state, electrical stimulation is delivered to a second portion of the brain to activate an arousal neural network in the first portion of the brain to induce a second arousal state to treat the cognitive disorder, where the second arousal state is different than the first arousal state.

摘要翻译： 在一些实例中，患者的脑的唤醒网络可以被激活以修改患者的觉醒状态，其可用于治疗患者的认知障碍。 在一些实例中，监测指示脑的第一部分中的电活动的生物电脑信号，以确定患者是否处于第一觉醒状态，并且响应于确定患者处于第一次唤醒状态，电刺激 被输送到大脑的第二部分以激活脑的第一部分中的觉醒神经网络以诱导第二觉醒状态来治疗认知障碍，其中第二觉醒状态不同于第一觉醒状态。